0000950123-21-002048.txt : 20210216 0000950123-21-002048.hdr.sgml : 20210216 20210212181334 ACCESSION NUMBER: 0000950123-21-002048 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210216 DATE AS OF CHANGE: 20210212 EFFECTIVENESS DATE: 20210216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ponoi Management, LLC CENTRAL INDEX KEY: 0001720702 IRS NUMBER: 821659880 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-19916 FILM NUMBER: 21630590 BUSINESS ADDRESS: STREET 1: 1700 OWENS STREET STREET 2: SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 4158652050 MAIL ADDRESS: STREET 1: 1700 OWENS STREET STREET 2: SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001720702 XXXXXXXX 12-31-2020 12-31-2020 false Ponoi Management, LLC

1700 OWENS STREET SUITE 500 San Francisco CA 94158

13F HOLDINGS REPORT 028-19916 Y Certain shares holdings that are reported on this 13F were previously reported on a 13F filed by Peter Svennilson (CIK: 0001606074) (File No. 028-16412) James Evangelista (415) 865-2050 /s/ James Evangelista San Francisco CA 02-12-2021 0 5 174792 false INFORMATION TABLE 2 3178.xml INFORMATION TABLE FOR FORM 13F Constellation Pharmaceuticals Inc. COM 210373106 54162 1880623 SH SOLE 0 1880623 0 Revolution Medicines Inc COM 76155X100 27120 685011 SH SOLE 0 685011 0 RAPT Therapeutics Inc COM 75382E109 31588 1599417 SH SOLE 0 1599417 0 NGM Biopharmaceuticals Inc COM 62921N105 39357 1298908 SH SOLE 0 1298908 0 Nurix Therapeutics Inc COM 67080M103 22565 686274 SH SOLE 0 686274 0